Research Topics
| Stephan HeresSummaryAffiliation: Klinikum rechts der Isar Country: Germany Publications
|
Detail Information
Publications
Language bias in neuroscience--is the Tower of Babel located in Germany?S Heres
Psychiatrische Klinik und Poliklinik, Technischen Universitaet Muenchen, Klinikum rechts der Isar, Ismaningerstrasse 22, Munich 81675, Germany
Eur Psychiatry 19:230-2. 2004..In the neurosciences a similar trend was seen but the findings were not statistically significant. The reason for this inconclusive finding might be the low number of RCTs published in German...
Patients' acceptance of the deltoid application of risperidone long-acting injectionStephan Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie, der Technischen Universitaet Muenchen, am Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Muenchen, Germany Electronic address
Eur Neuropsychopharmacol 22:897-901. 2012..Therefore offering both injection locations with their respective pros and cons should become standard in the RLAI treatment offered...
Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophreniaS Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie, der Technischen Universitaet Muenchen, am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Muenchen, Germany
Eur Psychiatry 26:297-301. 2011..Despite good clinical evidence, depot antipsychotics are only seldom prescribed to patients with first episode schizophrenia. The present study aims at investigating psychiatrists' reasons for this reservation...
Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysisStephan Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Muenchen, Germany
Prog Neuropsychopharmacol Biol Psychiatry 32:1987-93. 2008..In a first step to highlight this contradiction we aimed at identifying attributes of patients that indicate their qualification for depot treatment in the eyes of the psychiatrists...
The attitude of patients towards antipsychotic depot treatmentStephan Heres
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technical University Munich, am Klinikum rechts der Isar, Moehlstrasse 26, D 81675 Munich, Germany
Int Clin Psychopharmacol 22:275-82. 2007..A considerable number of patients would accept a depot drug as a long-term treatment option. The gap between patients' acceptance and the low prescription rates can be narrowed by offering antipsychotic depots to more patients...
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychoticsStephan Heres
Klinik und Poliklinik für Psychiatrie und Psychotherapie der Technischen Universität München am Klinikum rechts der Isar, Moehlstrasse 26, 81675 Munich, Germany
Am J Psychiatry 163:185-94. 2006....
Attitudes of psychiatrists toward antipsychotic depot medicationStephan Heres
Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen, Universitaet Muenchen am Klinikum rechts der, Muenchen, Germany
J Clin Psychiatry 67:1948-53. 2006..Nevertheless, long-acting injectable formulations are seldom prescribed in the treatment of schizophrenia...
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysisStefan Leucht
Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Klinikum rechts der Isar, Munich, Germany
Lancet 379:2063-71. 2012..We aimed to assess the association between such drugs and various outcomes in patients with schizophrenia to resolve controversial issues...
How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?Johannes Hamann
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universitat Munchen, Germany
Eur Neuropsychopharmacol 20:276-9. 2010..Other psychiatrist-related factors (e.g. age, gender, and work experience) did not influence attitudes toward depot...
Maintenance treatment with antipsychotic drugs for schizophreniaStefan Leucht
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Munchen, Germany
Cochrane Database Syst Rev 5:CD008016. 2012..Antipsychotic drugs block the transmission of dopamine in the brain and reduce the acute symptoms of the disorder. This review examined whether antipsychotic drugs are also effective for relapse prevention...
Evidence-based pharmacotherapy of schizophreniaStefan Leucht
Department of Psychiatry and Psychotherapy, Technische Universitat Munchen, Klinikum rechts der Isar, Munchen, Germany
Int J Neuropsychopharmacol 14:269-84. 2011..Although the randomized evidence on a superiority of depot compared to oral treatment is not ideal, this approach suggests obvious advantages in assuring compliance...
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophreniaStefan Leucht
Klinik und Poliklinik fur Psychiatrie und Psychotherapie, Klinikum rechts der Isarder, Technischen Universitat Munchen, Ismaningerstrasse 22, 81675 Munich, Germany
J Clin Psychiatry 67:3-8. 2006..Among the measures that have the potential to improve adherence to medication are psychosocial interventions, psychoeducation in the form of professional, peer-to-peer or family-to-family interventions, and shared decision making...
Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topicsJohannes Hamann
Department of Psychiatry, Technische Universitat Munchen, Möhlstrasse 26, 81675 Munchen, Germany
Psychiatr Serv 60:1107-12. 2009..This study explored psychiatrists' views of shared decision making in schizophrenia treatment...
Methodological issues in current antipsychotic drug trialsStefan Leucht
Department of Psychiatry and Psychotherapy, Klinikum rechts der Isar der Technischen Universitat Munchen, Ismaningerstr 22, 81675 Munchen, Germany
Schizophr Bull 34:275-85. 2008..The authors present practical examples to highlight the current problems and propose a concrete series of suggestions on how to further optimize antipsychotic drug trials in the future...
Pretrial medication bias in randomized antipsychotic drug trialsStefan Leucht
Am J Psychiatry 164:1266; author reply 1266-7. 2007
